Heparin in acute coronary disease - Requiem for a heavyweight?

被引：28

作者：

Armstrong, PW

机构：

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1997年 / 337卷 / 07期

关键词：

D O I：

10.1056/NEJM199708143370710

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：492 / 494

页数：3

相关论文

共 13 条

[1] HEPARIN - DO WE UNDERSTAND ITS ANTITHROMBOTIC ACTIONS
CINES, DB
[J]. CHEST, 1986, 89 (03) : 420 - 426
[2] A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease
Cohen, M
Demers, C
Gurfinkel, EP
Turpie, AGG
Fromell, GJ
Goodman, S
Langer, A
Califf, RM
Fox, KAA
Premmereur, J
Bigonzi, F
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (07) : 447 - 452
[3] *FRAGM INST COR AR, 1996, LANCET, V347, P561
[4] Task force 1. Pathogenesis of coronary disease: The biologic role of risk factors
Fuster, V
Gotto, AM
Libby, P
Loscalzo, J
McGill, HC
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (05) : 964 - 976
[5] *GLOB US STRAT OP, 1996, NEW ENGL J MED, V335, P775
[6] LOW-MOLECULAR-WEIGHT HEPARIN VERSUS REGULAR HEPARIN OR ASPIRIN IN THE TREATMENT OF UNSTABLE ANGINA AND SILENT ISCHEMIA
GURFINKEL, EP
MANOS, EJ
MEJAIL, RI
CERDA, MA
DURONTO, EA
GARCIA, CN
DAROCA, AM
MAUTNER, B
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (02) : 313 - 318
[7] HIRSH J, 1992, BLOOD, V79, P1
[8] HEPARIN - MECHANISM OF ACTION, PHARMACOKINETICS, DOSING CONSIDERATIONS, MONITORING, EFFICACY, AND SAFETY
HIRSH, J
RASCHKE, R
WARKENTIN, TE
DALEN, JE
DEYKIN, D
POLLER, L
[J]. CHEST, 1995, 108 (04) : S258 - S275
[9] Klein W, 1997, CIRCULATION, V96, P61
[10] A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
Levine, M
Gent, M
Hirsh, J
Leclerc, J
Anderson, D
Weitz, J
Ginsberg, J
Turpie, AG
Demers, C
Kovacs, M
Geerts, W
Kassis, J
Desjardins, L
Cusson, J
Cruickshank, M
Powers, P
Brien, W
Haley, S
Willan, A
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) : 677 - 681